Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

INHIXA Solution for Injection 4000 Anti-Xa IU (40MG)/0.4ML - HSA Drug Approval Details

Approvals/HSA/INHIXA Solution for Injection 4000 Anti-Xa IU (40MG)/0.4ML

Approved

THERAPEUTIC

INHIXA Solution for Injection 4000 Anti-Xa IU (40MG)/0.4ML

Shenzhen Techdow Pharmaceutical Co., Ltd.🇸🇬 Health Sciences Authority

Approval Date: May 7, 2024
Approval ID: cd85075f398a76e4
Company: Shenzhen Techdow Pharmaceutical Co., Ltd.
Type: Therapeutic

Approval Details

Approval Id: cd85075f398a76e4
Drug Name: INHIXA Solution for Injection 4000 Anti-Xa IU (40MG)/0.4ML
Product Name: INHIXA Solution for Injection 4000 Anti-Xa IU (40MG)/0.4ML
Approval Number: SIN16998P
Approval Date: 2024-05-07
Registrant: PHARMAZEN MEDICALS PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, SOLUTION
Route Of Administration: SUBCUTANEOUS, INTRAVENOUS BOLUS
Atc Code: B01AB05
Pharma Manufacturer Name: PHARMAZEN MEDICALS PTE LTD
Company Detail Path: /organization/4dd0b1ec78308c41/pharmazen-medicals-pte-ltd

Active Ingredients

Enoxaparin Sodium

4000 IU (40 MG)/0.4 ML

Enoxaparin Sodium

4000 IU (40 MG)/0.4 ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

May 7, 2024

Approval ID

cd85075f398a76e4

Type

Therapeutic

Back to HSA Approvals